This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

Erasca, Inc.

Tango Therapeutics, Inc.

Enliven Therapeutics, Inc.

Spyre Therapeutics, Inc.

Oruka Therapeutics, Inc.

Rezolute, Inc.

Liquidia Corporation

Alumis Inc. Common Stock

Definium Therapeutics, Inc.

Revolution Medicines, Inc.

Healthcare

Virtus Biotech Clinical Trials ETF

BBC Holdings & Sector Breakdown

BBC Holdings & Sector Breakdown